Pharmaron, I-Mab and Burning Rock Get Investor Validation From MSCI
Three up-and-coming Chinese pharma companies are among those included in latest adjustment for the index compiler’s China All Shares Index Key takeaways: MSCI’s addition of Pharmaron, I-Mab and Burning Rock…
